✦ LIBER ✦

Cisplatin/gemcitabine (CG) vs cisplatin/gemcitabine/vinorelbine (CGV) vs sequential doublets of gemcitabine/vinorelbine followed by ifosfamide/vinorelbine (GV/IV) in advanced non-small cell lung cancer. Interim analysis of a Spanish Lung Cancer Group (SLCG) phase III trial

✍ Scribed by Alberola, V; Camps, C; Provencio, M; Isla, D; Vadell, C; Pérez Carrión, R; González-Larriba, J.L; Azagra, P; Diz, P; Artal, A; Sánchez, J.J; Rosell, R

Book ID: 118569741
Publisher: Elsevier Science
Year: 2000
Tongue: English
Weight: 112 KB
Volume: 29
Category: Article
ISSN: 0169-5002
DOI: 10.1016/s0169-5002(00)80196-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cisplatin/gemcitabine (CG) vs cisplatin/

Cisplatin/gemcitabine (CG) vs cisplatin/gemcitabine/vinorelbine (CGV) vs sequential doublets of gemcitabine/vinorelbine followed by ifosfamide/vinorelbine (gv/iv) in advanced non-small cell lung cancer (NSCLC): final results of a Spanish lung cancer group phase III trial (GEPC/98-02)

✍ C. Camps; V. Alberola; M. Provencio; D. Isla; R. Rosell; C. Vadell; I. Bover; A. 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 164 KB

Cisplatin-gemcitabine-vinorelbine (PGV)

Cisplatin-gemcitabine-vinorelbine (PGV) vs cisplatin-vinorelbine (PV) vs cisplatin-gemcitabine (PG) in advanced non-small cell lung cancer (NSCLC). Interim analysis of a SICOG phase III trial

✍ P. Comella; N. Panza; G.P. Nicolella; L. Manzione; V. Lorusso; R. Cioffi; G. Dec 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 146 KB

Commentary on “Interim Analysis of a Pha

Commentary on “Interim Analysis of a Phase III Trial Comparing Cisplatin, Gemcitabine, and Vinorelbine vs. Either Cisplatin and Gemcitabine or Cisplatin and Vinorelbine in Advanced Non–Small-Cell Lung Cancer (NSCLC)”

✍ Gregory A. Masters 📂 Article 📅 2000 🏛 CIG Media Group, LP. 🌐 English ⚖ 350 KB

Cisplatin-gemcitabine, vs. cisplatin-gem

Cisplatin-gemcitabine, vs. cisplatin-gemcitabine-vinorelbine, vs. cisplatin-gemcitabine-paclitaxel in advanced non-small-cell lung cancer. First-stage analysis of a Southern Italy Cooperative Oncology Group (SICOG) phase III trial

✍ Comella, P; Frasci, G; Panza, N; Nicolella, G; Manzione, L; De Cataldis, G; Ciof 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 103 KB

Gemcitabine and cisplatin versus vinorel

Gemcitabine and cisplatin versus vinorelbine and cisplatin versus ifosfamide+gemcitabine followed by vinorelbine and cisplatin versus vinorelbine and cisplatin followed by ifosfamide and gemcitabine in stage IIIB–IV non small cell lung carcinoma: a prospective randomized phase III trial of the Gruppo Oncologico Italia Meridionale

✍ Gebbia, V 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 180 KB

Gemcitabine + vinorelbine (GV) vs vinore

Gemcitabine + vinorelbine (GV) vs vinorelbine (V) alone in elderly or frail non-small cell lung cancer (NSCLC) patients. Interim analysis of a SICOG phase III trial

✍ G. Frasci; V. Lorusso; N. Panza; G. DeCataldis; F. Del Gaizo; G.P. Nicolella; V. 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 183 KB